Toxoplasmosis

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

GSK
GSKLONDON, United Kingdom
1 program
1
PyrimethaminePhase 11 trial
Active Trials
NCT03258762Completed14Est. Nov 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GSKPyrimethamine

Clinical Trials (1)

Total enrollment: 14 patients across 1 trials

NCT03258762GSKPyrimethamine

Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects

Start: Sep 2017Est. completion: Nov 201714 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space